COVID-19 vaccine makers tell Congress U.S. supply will surge soon

COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations. Executives from Pfizer Inc, Moderna Inc and Johnson & Johnson - speaking at a hearing at the U.S. House of Representatives - said they would be able to supply enough vaccine to fully inoculate 130 million people in the United States by the end of March.

Reuters | Washington DC | Updated: 24-02-2021 00:40 IST | Created: 24-02-2021 00:39 IST
COVID-19 vaccine makers tell Congress U.S. supply will surge soon
Representative Image Image Credit: ANI

COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.

Executives from Pfizer Inc, Moderna Inc and Johnson & Johnson - speaking at a hearing at the U.S. House of Representatives - said they would be able to supply enough vaccine to fully inoculate 130 million people in the United States by the end of March. The drugmakers also reaffirmed their commitments to supply more than enough doses necessary to vaccinate all Americans by the end of July.

Pfizer Chief Business Officer John Young said it was plausible that there could be a surplus of vaccine in the United States sometime in the second quarter of this year. "We certainly hope that we're going to be in a position where every eligible adult will be able to receive vaccinations," Young said.

Around 44.5 million people in the United States had received at least one dose of two-shot vaccines developed by Pfizer and BioNTech or Moderna, as of Tuesday morning. Johnson & Johnson's single-dose vaccine will be considered by an outside advisory committee to the U.S. Food and Drug Administration later this week, and emergency use authorization could come shortly afterward.

Richard Nettles, Vice President of Medical Affairs at J&J's Janssen Pharmaceuticals unit, said the company would be able to ship nearly 4 million doses of its COVID-19 vaccine upon authorization and 20 million doses by the end of March. Additional doses could also come from AstraZeneca Plc and from Novavax Inc, which are currently running clinical trials of their experimental vaccines.

An AstraZeneca executive said the drugmaker could supply doses necessary to vaccinate another 25 million people by the end of April if their vaccine is authorized by U.S. regulators.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

FEATURE-Vulnerable children stay shut indoors in UK with no vaccine in sight

By Emma Batha LONDON, March 1 Thomson Reuters Foundation - When Britains children return to school next week as the country eases its third lockdown, six-year-old Daniel Meredith will not be joining his friends but will remain shut indoors ...

TDP chief detained at Tirupati airport, stages sit-in protest

EDS RPT after updating with SPs press meet departure of Naidu to Hyderabad Tirupati Andhra Pradesh, Mar 1 PTI Leader of Opposition in the Andhra Pradesh Assembly N Chandrababu Naidu staged a sit-in protest in the arrival lounge of the airpo...

Cut money charge: Narayanasamy threatens to sue Amit Shah, asks him to prove or apologise

Former Puducherry Chief Minister V Narayanasamy on Monday threatened to sue Union Home Minister Amit Shah over his cut money charge, rejecting it as baseless and asking him to prove it or apologise to people.A day after Shah accused him of ...

Toolkit case: Nikita Jacob moves Delhi court for anticipatory bail New De'

Nikita Jacob, who is accused along with Disha Ravi in connection with allegedly being involved in sharing a toolkit on social media related to the farmers protest, Monday moved a Delhi court seeking anticipatory bail.The application moved b...

Give Feedback